March 7, 2025

Updated Analysis of ADHD Prevalence in The United States

The National Health Interview Survey (NHIS) is conducted annually by the National Center for Health Statistics at the Centers for Disease Control and Prevention. The NHIS is done primarily through face-to-face computer-assisted interviews in the homes of respondents. But telephone interviews are substituted on request, or where travel distances make in-home visits impractical.  

For each interviewed family, only one sample child is randomly selected by a computer program.  

The total number of households with a child or adolescent aged 3-17 for the years 2018 through 2021 was 26,422. 

Based on responses from family members, 9.5% of the children and adolescents randomly surveyed throughout the United States had ADHD.  

This proportion varied significantly based on age, rising from 1.5% for ages 3-5 to 9.6% for ages 6-11 and to 13.4% for ages 12-17. 

There was an almost two-to-one gap between the 12.4% prevalence among males and the 6.6% prevalence among females. 

There was significant variation by race/ethnicity. While rates among non-Hispanic whites (11.1%) and non-Hispanic blacks (10.5%) did not differ significantly, these two groups differed significantly from Hispanics (7.2%) and Others (6.6%). 

There were no significant variations in ADHD prevalence based on highest education level of family members. 

But family income had a significant relationship with ADHD prevalence, especially at lower incomes. For family incomes under the poverty line, the prevalence was 12.7%. That dropped to 10.3% for family incomes above the poverty level but less than twice that level. For all others it dropped further to about 8.5%. Although that might seem like poverty causes ADHD, we cannot draw that conclusion.  Other data indicate that adults with ADHD have lower incomes.  That would lead to more ADHD in kids from lower income families.

There was also significant geographic variation in reported prevalence rates. It was highest in the South, at 11.3%, then the Midwest at 10%, the Northeast at 9.1%, with a jump down to 6.9% in the West. 

Overall ADHD prevalence did not vary significantly by year over the four years covered by this study. 

Study Conclusion:

This study highlights a consistently high prevalence of developmental disabilities among U.S. children and adolescents, with notable increases in other developmental delays and co-occurring learning and intellectual disabilities from 2018 to 2021. While the overall prevalence remained stable, these findings emphasize the need for continued research into potential risk factors and targeted interventions to address developmental challenges in youth.

It is also important to note that this study assessed the prevalence of ADHD being diagnosed by healthcare professionals.  Due to variations in healthcare accessibility across the country, the true prevalence of ADHD may differ still.

...

Are you struggling to get the care you need to manage your ADHD? Support The ADHD Evidence Project and get this step-by-step guide to getting the treatment you deserve: https://bit.ly/41gIQE9

Qian Li, Yanmei Li, Juan Zheng, Xiaofang Yan, Jitian Huang, Yingxia Xu, Xia Zeng, Tianran Shen, Xiaohui Xing, Qingsong Chen, and Wenhan Yang, “Prevalence and trends of developmental disabilities among US children and adolescents aged 3 to 17 years, 2018–2021,” Scientific Reports (2023) 13: 17254, https://doi.org/10.1038/s41598-023-44472-1

Related posts

Update: New Research about ADHD in Adults

Update: New Research about ADHD in Adults

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that is typically diagnosed in childhood but can persist into adulthood. Its symptoms include inattention, hyperactivity, and impulsivity, and it can significantly affect daily life, academic achievement, and professional success. As scientific understanding of the condition continues to evolve, new research is revealing more insights into the prevalence, comorbidity, treatment, and physiological aspects of ADHD in adults. Here's a roundup of some recent findings:

Location of Mental Healthcare and ADHD Treatment Prevalence

A recent study assessing the prevalence of treatment for ADHD among US college students found that the location of mental health care significantly affects treatment outcomes. Specifically, students receiving mental healthcare on campus were less likely to receive any medication or therapy for ADHD, suggesting the need to evaluate the quality of mental health services available on college campuses and their effectiveness in treating ADHD.

 Oxidative Stress and l-Arginine/Nitric Oxide Pathway in ADHD 

Another study found a correlation between ADHD and the l-Arginine/Nitric oxide (Arg/NO) pathway, a physiological process linked to dopamine release and cardiovascular functioning. The study found that adults with ADHD who were not treated with methylphenidate (a common ADHD medication) showed variations in the Arg/NO pathway. This could have implications for monitoring potential cardiovascular side effects of ADHD medications, as well as for understanding the biochemical changes that occur in ADHD. 

Chronic Pain in ADHD

ADHD and chronic pain appear to be related, according to a comparative study of clinical and general population samples. Particularly in females with ADHD, the prevalence of chronic and multisite pain was found to be high. This calls for longitudinal studies to understand the complex sex differences of comorbid chronic pain and ADHD in adolescents and the potential impacts of stimulant use on pain.

ADHD and Violent Behavior

Finally, a study investigated the comorbidity of ADHD and bipolar disorder (BD) and its potential link to violent behavior. The research revealed a positive effect of ADHD symptoms on violence tendency and aggression scores. Moreover, male gender and young age were also found to have significant positive effects on violence and aggression scores, suggesting an association between these disorders and violent behavior.

June 3, 2024

New Zealand national birth cohort finds young adults with ADHD overrepresented at all stages of the criminal justice system

National Birth Cohort Finds Young Adults with ADHD Over-represented in Criminal Justice System

Using Statistics New Zealand’s Integrated Data Infrastructure (IDI), a large database of linked de-identified administrative and survey data about people and households, a local study team examined a three-year birth cohort (mid-1992 through mid-1995) totaling 149,076 persons.

The team assessed the presence of ADHD within this cohort through diagnosis codes and inference from medication dispensing, where there was at least one code relating to an ADHD diagnosis in the medication datasets. This subgroup consisted of 3,975 persons.

Next, they related this information to criminal justice system interactions of increasing severity, starting with police proceedings, and continuing with court charges, court convictions, and incarcerations. These interactions were tracked during an eight-year period from participants’ 17th birthday through their 25th birthday.

In this same period the team also tracked types of offenses: against people; against property; against organizations, government, and community; and violent offenses.

In all cases, the study team adjusted for gender, ethnicity, deprivation, and area of residence as potential confounders. 

With these adjustments, young adults with ADHD were over twice as likely as their typically developing peers to be proceeded against by police, to be charged with an offense, and to be convicted. They were almost five times as likely to be incarcerated. 

With the same adjustments, young adults with ADHD were over twice as likely as their typically developing peers to be convicted of offenses against organizations, government, and community. They were almost three times as likely to be convicted of crimes against persons, and over three and a half times more likely to be convicted of either violent offenses or offenses against property.

The authors noted, “The greater effect size for incarceration observed in our study may be due to the lack of control for comorbid conditions such as CD [conduct disorder], which are known criminogenic risk factors.” 

They also noted, “The sharp increase in the risk of incarceration observed may also signal differences in the NZ justice system’s approach to ADHD, which may be less responsive to the condition than other nations, particularly the steps in the justice system between conviction and sentence. This would suggest that the UNCRPD [United Nations Convention on the Rights of Persons with Disabilities] obligations of equal recognition before the law and the elimination of discrimination on the basis of disability are not being met for individuals with ADHD in NZ.”

They concluded, “Our findings revealed that not only were individuals with ADHD overrepresented at all stages of the CJS [criminal justice system] and offense types examined, there was also a pattern of increasing risk for CJS interactions as these individuals moved through the system. These results highlight the importance of early identification and responsivity to ADHD within the CJS and suggest that the NZ justice system may require changes to both of these areas to ensure that young individuals with ADHD receive equitable access to, and treatment within, the CJS.”

New Estimates on Worldwide Prevalence of ADHD

Meta-analysis updates estimates of adult ADHD prevalence worldwide

An international team of researchers conducted a comprehensive search of the peer-reviewed literature to perform a meta-analysis, with three aims:

1) assess the global prevalence of adult ADHD

2) explore possible associated factors

3) estimate the 2020 global population of persons with adult ADHD.

In doing so, they distinguished between studies requiring childhood-onset of ADHD to validate adult ADHD (persistent adult ADHD) and studies that make no such requirement and examine ADHD symptoms in adults regardless of previous childhood diagnosis (symptomatic adult ADHD).

The search yielded forty articles covering thirty countries. Twenty reported prevalence data on symptomatic adult ADHD, 19 on persistent adult ADHD, and one on both. Thirty-five studies were published in the last decade (2010-2019). Thirty-one included both urban and rural populations. Thirty-five had a quality score of six or above (out of ten). Twenty-five had sample sizes greater than a thousand.

Because the prevalence of ADHD is age-dependent, and different countries vary widely in the age structure of their populations, the authors adjusted country results for their structures. This allowed for meaningful global estimates of the prevalence of adult ADHD.

Twenty studies covering a total of 107,282 participants reported the prevalence of persistent adult ADHD. The pooled prevalence was 4.6%. After adjustment for the global population structure, the pooled prevalence was 2.6%, equivalent to roughly 140 million cases globally.

Twenty-one studies covering 50,098 participants reported on the prevalence of symptomatic adult ADHD. The pooled prevalence was 8.8%. After adjustment for the global population structure, the pooled prevalence was 6.7%, equivalent to roughly 366 million cases globally.

For persistent adult ADHD, adjusted prevalence declined steeply from 5% among 18- to 24-year-olds to 0.8% among those 60 and older.

For symptomatic adult ADHD, adjusted prevalence declined less steeply from 9% among 18- to 24-year-olds to 4.5% among that 60 and older.

In each case, subgroup analyses found no significant differences based on sex, urban or rural setting, diagnostic tool, DSM version, or investigation period, although pooled prevalence estimates of persistent adult ADHD from 2010 onward were almost twice the previous pooled prevalence estimates. For symptomatic adult ADHD, however, differences between WHO (World Health Organization) regions were highly significant, although the outliers(Southeast Asia at 25% and Eastern Mediterranean at 16%) were based on small samples(304 and 748 respectively).

In both cases, between-study heterogeneity was very high (over 97%). The authors noted, "the age of interviewed participants in the included studies was not unified, ranging from young adults to the elderly. Given the fact that the prevalence of adult ADHD decreases with advancing age, as revealed in previous investigations and our meta-regression, it is not surprising to observe such a diversity in the reported prevalence, and the considerable heterogeneity across included studies could not be fully ruled out by a priori selected variables, including diagnostic tool, DSM version, sex, setting, investigation period, WHO region, and WB [World Bank] region. The effects of other potential correlates of adult ADHD, such as ethnicity, were not able to be addressed due to the lack of sufficient information."

In both cases, there was also evidence of publication bias. The authors stated, "we did not try to eliminate publication bias in our analyses, because we deemed that an observed prevalence of adult ADHD that substantially differed from previous estimates was likely to have been published."

January 30, 2022

Study Finds Association Between Childhood ADHD and Poor Dental Health

The Spanish National Health Survey tracks health care outcomes through representative samples of the Spanish population. 

A Spanish research team used survey data to explore the relationship between ADHD symptoms and dental and gum health in a representative sample of 3,402 Spanish children aged 6 to 14.

While previous studies have found associations between ADHD and poor dental health, they have not fully accounted for such important determinants of poor oral health as socioeconomic status, dental hygiene, or diet. 

The team therefore adjusted for sociodemographic factors, lifestyle variables, and oral hygiene behaviors. More specifically, they adjusted for sex, age, social class, parental education, exposure to tobacco smoke, consumption of sweets, consumption of sugary drinks, use of asthma or allergy medication, adequate oral hygiene behavior of children, adherence to regular dental visits, parental adequate oral hygiene behavior, and parental adherence to regular dental visits.

With those adjustments, children with ADHD symptoms had over twice the incidence of dental caries (cavities) as their counterparts without ADHD symptoms.

Tooth extractions and dental restorations also occurred with over 40% greater frequency in children with ADHD symptoms.

Gum bleeding, a sign of gum disease, was more than 60% more common among children with ADHD symptoms than among their non-ADHD peers.

Importantly, excluding children with daily sugar consumption, which left 1,693 children in the sample, made no difference in the outcome for cavities.

Excluding children with poor oral hygiene habits, which left 1,657 children in the sample, those with ADHD had 2.5-fold more caries than their non-ADHD counterparts.

Excluding children of low social class, which left 1,827 children in the sample, those with ADHD had 2.6-fold more caries than their non-ADHD counterparts.

Turning to a different method to address potential confounding factors, the team used nearest-neighbor propensity score matching to create virtual controls. This compared 461 children with ADHD to 461 carefully matched children without ADHD.

This time, children with ADHD symptoms had just under twice the incidence of cavities as their counterparts without ADHD symptoms, but 60% more tooth extractions and about 75% more dental restorations. The difference in gum bleeding became nonsignificant.

Noting that “The increased risk of caries was maintained when the analyses were restricted to middle/high social class families and children with low sugar intake, good oral hygiene behaviors and regular dental visits,” the team concluded, “Children with ADHD symptoms in Spain had worse oral health indicators than those without ADHD symptoms. Our results suggest that the association of ADHD symptoms with caries was independent of socioeconomic level, cariogenic diet, frequency of toothbrushing, and dental visits.”

June 13, 2025

A Lesson in Correlation Versus Causation : Maternal Smoking and ADHD Risk in Children

Meta-analysis Finds Strong Link Between Maternal Smoking During Pregnancy and Increased Risk of ADHD in Children

This new meta-analysis confirms what other meta-analysis have already shown, i.e, that there exists in the population an association between maternal smoking during pregnancy and ADHD in their offspring.  But reader beware, association does not mean causation.

The team identified 55 studies with quantitative data suitable for meta-analysis, including 11 case-control, 13 cross-sectional, and 31 retrospective/prospective cohort studies. 

Altogether they combined more than four million persons in countries spanning six continents, including the United States, Finland, Sweden, Brazil, the Netherlands, Japan, the UK, Spain, China, Australia, New Zealand, Norway, Canada, France, Sweden, South Korea, Turkey, Romania, Bulgaria, Lithuania, Germany, Denmark, Egypt, and India.

Meta-analysis of all 55 studies found that offspring of mothers who smoked tobacco during pregnancy were about 70% more likely to develop ADHD than offspring of mothers who did not smoke during pregnancy.

Because variation in outcomes across studies was very high, the team performed subgroup analyses to explore potential sources of this heterogeneity. 

Comparing study designs, cohort studies reported roughly 50% greater odds of ADHD among children of mothers who smoked during pregnancy, whereas case-control studies reported roughly 70% greater odds and cross-sectional studies 2.3-fold greater odds.

Studies using the most reliable method of determining ADHD – clinical interview/professional diagnosis – reported 90% greater odds, contrasting with 66% through medical records/databases and 58% through self-report by child/parent or through teacher report.

Good quality studies reported roughly 75% greater odds. 

Studies with sample sizes above two thousand similarly found 70% greater odds.

There was no sign of publication bias using the more commonly used Egger’s test, but a marginal indication of publication bias using Begg’s test. Performing a standard correction reduced the effect size, indicating that the offspring of mothers who smoked tobacco during pregnancy were over 50% more likely to develop ADHD than the offspring of mothers who did not smoke during pregnancy.

The team concluded, “This systematic review and meta-analysis of 55 studies, encompassing over four million participants, provides compelling evidence that maternal tobacco smoking during pregnancy significantly increases the odds of ADHD in children … These findings underscore the critical need for public health interventions aimed at reducing tobacco smoking during pregnancy.”

However, we disagree with this conclusion; The authors ignore substantial evidence showing that maternal smoking during pregnancy is confounded by maternal ADHD. These mothers transmit ADHD via genetics, not via their smoking. This study should be seen not as "...[further evidence that smoking during pregnancy causes ADHD.] ", but as a lesson in how easy it can be to see correlation as causation.

------

Struggling with side effects or not seeing improvement in your day-to-day life? Dive into a step-by-step journey that starts with the basics of screening and diagnosis, detailing the clinical criteria healthcare professionals use so you can be certain you receive an accurate evaluation. This isn’t just another ADHD guide—it’s your toolkit for getting the care you deserve. This is the kind of care that doesn’t just patch up symptoms but helps you unlock your potential and build the life you want. Whether you’ve just been diagnosed or you’ve been living with ADHD for years, this booklet is here to empower you to take control of your healthcare journey.

Proceeds from the sale of this book are used to support www.ADHDevidence.org.

Get the guide now– Navigating ADHD Care: A Practical Guide for Adults

June 10, 2025

Meta-analysis Finds Little Evidence of Efficacy for Animal-Assisted Interventions for Treating Childhood ADHD

Study Background:

Animal-assisted interventions (AAIs) involve structured interactions with animals, designed and carried out by mental health teams assisted by trained human–animal professionals, to achieve specific therapeutic or educational goals. While a wide variety of animals may be used, horses and dogs tend to predominate. These interventions often involve physical contact, imitation, and play aimed at reducing stress and generating affection. Previous research has suggested that AAI to those with a range of developmental and mental health conditions.

Just how effective are they for treating ADHD in children and adolescents? Recent years have seen an increase in studies into AAIs for children with ADHD, but previous systematic reviews have not included quantitative meta-analysis to evaluate efficacy.

The Study:

A Chinese study team based in Nanjing set out to remedy that with a systematic search of the peer-reviewed published medical literature aimed at performing meta-analyses of efficacy.

The team limited its search to randomized controlled trials (RCTs) and pre–post single-group studies involving children and adolescents diagnosed with ADHD.

Meta-analysis of five studies with a combined total of 95 participants reported no significant effect of AAIs on ADHD symptom severity. There was negligible variation (heterogeneity) in outcomes among the studies.

Similarly, meta-analysis of the six studies encompassing 323 individuals found no significant improvements in social behavior. There was no heterogeneity and no sign of publication bias. Breaking that down into subcategories of social interaction (4 studies, 190 persons), social skill (3 studies, 53 persons), and problem behavior (4 studies, 80 participants) made no difference.

Likewise, meta-analysis of the three studies encompassing 61 individuals found no significant improvements in emotional control. Again, there was no heterogeneity and no sign of publication bias.

Three studies combining 56 participants reported no significant reductions in anxiety and depression, again with no heterogeneity and no sign of publication bias.

However, meta-analyses of five studies encompassing 194 individuals found a medium effect size association between AAIs and declines in attention problems, and a medium-to-large effect size improvement in learning and cognition. Heterogeneity was negligible to low.

Finally, meta-analysis of three studies combining 95 participants reported a large effect size improvement in motor proficiency, with moderate heterogeneity.

The Conclusion:

The team concluded, “As an ADHD management strategy complementary to gold-standard approaches, such as medication or multimodal interventions, AAIs did not appear to be more effective in improving the majority of core ADHD outcomes in children. Future studies should incorporate rigorous study designs with large sample sizes and a standard protocol to achieve more valid and reliable conclusions.”

June 5, 2025